Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2005
11/17/2005US20050256106 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder
11/17/2005US20050256104 Protease inhibitors
11/17/2005US20050256089 for use as pesticides, herbicides; condensation
11/17/2005US20050256078 Hepatitis C; toxicity, side effects reduction; improved pharmacological/pharmacokinetics properties; novel intermediates; increased cellular accumulation and retention of a drug compound, to improve their therapeutic and diagnostic value, comprising linking the compound to one or more phosphonate groups
11/17/2005US20050256066 Fredericamycin derivatives
11/17/2005US20050256000 Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use
11/17/2005US20050255465 Novel fluorescent label compounds
11/17/2005DE102004020908A1 Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen Substituted 5,6,7,8-tetrahydro-pyrido [4,3-d] pyrimidin-2-yl and 5,6,7,8-tetrahydro-quinazolin-2-yl compounds
11/17/2005DE102004020186A1 Heterocyclylessigsäuren als Inhibitoren von TAFla Heterocyclylessigsäuren as inhibitors of TAFIa
11/17/2005CA2566426A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/17/2005CA2565367A1 Dihydrobenzothiophenes
11/17/2005CA2565214A1 (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease
11/17/2005CA2564980A1 Novel beta agonists, method for producing the same and their use as drugs
11/16/2005EP1594876A1 Conducting polymers with porphyrin cross-linkers
11/16/2005EP1594867A2 Phenylacetamides and their use as glucokinase modulators
11/16/2005EP1594861A1 Triazole compounds and the therapeutic use thereof
11/16/2005EP1594860A2 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/16/2005EP1594856A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
11/16/2005EP1594841A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
11/16/2005EP1594840A1 Piperidine-benzenesulfonamide derivatives
11/16/2005EP1594505A2 Phenylglycine derivatives useful as serine protease inhibitors
11/16/2005EP1594501A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/16/2005EP1379516B1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists
11/16/2005EP1370557B1 Benzimidazole anti-inflammatory compounds
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1317442B1 Quinolinone derivatives as tyrosine kinase inhibitors
11/16/2005EP1257550B1 Platelet adp receptor inhibitors
11/16/2005EP1222182B1 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
11/16/2005EP1218374B1 Pharmaceutically active sulfonamide derivatives
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/16/2005CN1227231C Ether and amide compounds as medicine for treating glycuresis and preparing process thereof
11/16/2005CN1227228C Delta 1-pyrrolines used as pesticides
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/15/2005US6964939 Substituted thiene-3-yl-sulfonyl amino(thio)carbonyl-triazolin(thi)ones
11/10/2005WO2005105884A1 Monomer, oligomer and pi-conjugated polymer compounds, and photovoltaic cells containing same
11/10/2005WO2005105791A1 Indolyl derivatives as liver-x-receptor modulators
11/10/2005WO2005105790A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
11/10/2005WO2005105788A1 Indole derivatives and use thereof as kinase inhibitors
11/10/2005WO2005105781A1 Imidazole derivatives used as tafia inhibitors
11/10/2005WO2005105778A2 4-amino-5-cyanopyrimidine derivatives
11/10/2005WO2005105777A1 Substituted thiophene amide compounds for the treatment of inflammation
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105761A1 Morpholinylanilinoquinazo- line derivatives for use as antiviral agents
11/10/2005WO2005105760A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
11/10/2005WO2005105759A1 Substituted 5, 6, 7, 8-tetrahydro-pyrido[4, 3-d]pyrimidine-2-yl compounds and 5, 6, 7, 8-tetrahydro-quinazoline-2-yl compounds
11/10/2005WO2005105758A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005WO2005105757A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005WO2005105752A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
11/10/2005WO2005105725A1 Novel compounds, their preparation and use
11/10/2005WO2005087721A3 Compounds as inhibitors of hepatitis c virus ns3 serine protease
11/10/2005WO2005082858A3 Isoquinoline derivatives
11/10/2005WO2005075429B1 Novel quinoline-carbaxamides as jack3 kinase modulators
11/10/2005WO2004071428A3 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
11/10/2005US20050250829 Kinase inhibitors
11/10/2005US20050250810 Screening for an enzyme inhibitor of Fab I or Fab K using providing a reaction mixture comprising Fab I or Fab K, crotonyl-ACP and NAPDH or NADH; contacting a candidate compound with the reaction mixture; and detecting inhibition of Fab I or Fab K; bactericides; fungicides; antibiotics; Stapylococcus
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250770 Fused heterocyclic compounds
11/10/2005US20050250741 non-steroidal agonists and antagonists; 2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-1H-indole-5--carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005US20050248154 Threaded connection for oil field applications
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2564589A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005CA2564587A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005CA2564288A1 Substituted 5, 6, 7, 8-tetrahydro-pyrido[4, 3-d]pyrimidin-2-yl and 5, 6, 7, 8-tetrahydro-quinazolin-2-yl compounds
11/10/2005CA2564175A1 Chemical compounds
11/10/2005CA2564085A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
11/10/2005CA2562400A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/09/2005EP1592685A1 BIPHENYL DERIVATIVES HAVING &bgr; sb 2 /sb ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
11/09/2005EP1592684A1 Malonamide derivatives as gamma-secretase inhibitors
11/09/2005EP1592683A2 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
11/09/2005EP1592670A1 Mercaptoimidazoles as ccr2 receptor antagonists
11/09/2005EP1592389A2 Piperazine-2-carboxamide derivatives
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP1089973B1 Amidino and guanidino azetidinone tryptase inhibitors
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005CN1694879A Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1694869A Substituted spirocyclic ketoenols
11/09/2005CN1694708A Inhibitors of tgfbeta
11/09/2005CN1694700A Non-nucleoside reverse transcriptase inhibitors
11/09/2005CN1226292C Diazesuberane derivant or its salt
11/08/2005US6962995 Phenanthroline derivatives
11/08/2005US6962942 Azacycloalkanone serine protease inhibitors
11/08/2005US6962938 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
11/08/2005US6962932 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
11/08/2005US6962923 Pyrazole compositions
11/08/2005US6962917 E.g., (R)-2-(4-((4-fluoro-1H-benzimidazol-2-ylmethyl)-amino)-piperidin-1-yl)-1-(6- methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria
11/08/2005US6962916 For therapy of retrovirus infection
11/08/2005CA2249222C Aminopyridine derivatives
11/03/2005WO2005103039A1 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists
11/03/2005WO2005103033A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005WO2005103031A1 Novel alkyne compounds with an mch-antagonistic action and medicaments containing said compounds
11/03/2005WO2005103022A1 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
11/03/2005WO2005103006A1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
11/03/2005WO2005103002A2 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds
11/03/2005WO2005102335A2 Methods of treating sleep disorders